{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:03:50Z","timestamp":1767701030812,"version":"3.48.0"},"reference-count":46,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Top Talent of SZTU","award":["GDRC202121"],"award-info":[{"award-number":["GDRC202121"]}]},{"name":"Fundamental Research Funds for Shenzhen Technology University","award":["20211063010049"],"award-info":[{"award-number":["20211063010049"]}]},{"name":"Science and Technology Planning Project of Shenzhen Municipality","award":["JCYJ20190808122605563"],"award-info":[{"award-number":["JCYJ20190808122605563"]}]},{"name":"Science and Technology Planning Project of Shenzhen Municipality","award":["JCYJ20220530153206014"],"award-info":[{"award-number":["JCYJ20220530153206014"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2025.2607808","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:49:11Z","timestamp":1767700151000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Discovery of N8: a novel IKK\u03b5 inhibitor with potent anticancer activity via cytotoxicity, migration suppression, and autophagy modulation"],"prefix":"10.1080","volume":"41","author":[{"given":"Wei","family":"Ye","sequence":"first","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]},{"name":"School of Pharmaceutical Sciences, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Zheng","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Xie","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrui","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]},{"name":"School of Pharmaceutical Sciences, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiapeng","family":"Xu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]},{"name":"School of Pharmaceutical Sciences, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiting","family":"Luo","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]},{"name":"School of Pharmaceutical Sciences, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieyu","family":"Li","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Diao","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]},{"name":"School of Pharmaceutical Sciences, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyi","family":"Luo","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]},{"name":"School of Pharmaceutical Sciences, Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinchang","family":"Zhu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Liu","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Shenzhen Technology University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33587"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"issue":"1","key":"e_1_3_4_4_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13045-022-01362-9","article-title":"Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021","volume":"15","author":"Wu Q","year":"2022","unstructured":"Wu Q, Qian W, Sun XL, Jiang SJ. Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021. J Hematol Oncol. 2022;15(1):143.","journal-title":"J Hematol Oncol"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2015.07.010"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00195-4"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106552"},{"issue":"10","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41573-021-00303-4","article-title":"Trends in kinase drug discovery: targets, indications and inhibitor design","volume":"20","author":"Attwood MM","year":"2021","unstructured":"Attwood MM, Fabbro D, Sokolov AV, Knapp S, Schi\u00f6th HB. Trends in kinase drug discovery: targets, indications and inhibitor design. (Aug, 2021)Nat Rev Drug Discov. 2021;20(10):798\u2013798.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"eadk2285","DOI":"10.1126\/sciadv.adk2285","article-title":"Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis","volume":"10","author":"Gao B","year":"2024","unstructured":"Gao B, Wu X, Bu L, Jiang Q, Wang L, Liu H, Zhang X, Wu Y, Li X, Li J, et al. Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis. Sci Adv. 2024;10(6):eadk2285.","journal-title":"Sci Adv"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0229-6"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.08.036"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.03.052"},{"issue":"5","key":"e_1_3_4_13_1","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1159\/000373991","article-title":"Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma","volume":"35","author":"Tang D","year":"2015","unstructured":"Tang D, Sun B, Yu H, Yang Z, Zhu L. Tumor-suppressing effect of miR-4458 on human hepatocellular carcinoma. Cell Physiol Biochem. 2015;35(5):1797\u20131807.","journal-title":"Cell Physiol Biochem"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2023.102180"},{"issue":"1","key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1309\/AJCP2JJGYNIUAS2V","article-title":"I\u03baB Kinase \u03b5 expression in pancreatic ductal adenocarcinoma","volume":"136","author":"Cheng A","year":"2011","unstructured":"Cheng A, Guo J, Henderson-Jackson E, Kim D, Malafa M, Coppola D. I\u03baB Kinase \u03b5 expression in pancreatic ductal adenocarcinoma. Am J Clin Pathol. 2011;136(1):60\u201366.","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1093\/nar\/gkaa271","article-title":"IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway","volume":"48","author":"Bainbridge A","year":"2020","unstructured":"Bainbridge A, Walker S, Smith J, Patterson K, Dutt A, Ng YM, Thomas HD, Wilson L, McCullough B, Jones D, et al. IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway. Nucleic Acids Res. 2020;48(10):5366\u20135382.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.7150\/thno.40397","article-title":"IKK\u03b5 phosphorylates kindlin-2 to induce invadopodia formation and promote colorectal cancer metastasis","volume":"10","author":"Liu G","year":"2020","unstructured":"Liu G, Bao Y, Liu C, Zhu Q, Zhao L, Lu X, Zhu Q, Lv Y, Bai F, Wen H, et al. IKK\u03b5 phosphorylates kindlin-2 to induce invadopodia formation and promote colorectal cancer metastasis. Theranostics. 2020;10(5):2358\u20132373.","journal-title":"Theranostics"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0069"},{"issue":"1","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2353\/ajpath.2009.080767","article-title":"Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer","volume":"175","author":"Guo J-P","year":"2009","unstructured":"Guo J-P, Shu S-K, He L, Lee Y-C, Kruk PA, Grenman S, Nicosia SV, Mor G, Schell MJ, Coppola D, et al. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am J Pathol. 2009;175(1):324\u2013333.","journal-title":"Am J Pathol"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S204924"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9290.123382"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.06.006"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114895"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b01460"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2019-0307"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2019.06.004"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570180819666220922103109"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105740"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fchem.2019.00873","article-title":"In silico methods for design of kinase inhibitors as anticancer drugs","volume":"7","author":"Gagic Z","year":"2019","unstructured":"Gagic Z, Ruzic D, Djokovic N, Djikic T, Nikolic K. In silico methods for design of kinase inhibitors as anticancer drugs. Front Chem. 2019;7:873.","journal-title":"Front Chem"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520618666181009163014"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03819-2"},{"key":"e_1_3_4_32_1","unstructured":"RDKit: Open-source cheminformatics. http:\/\/www.rdkit.org."},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21256"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.0c01006"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/ci200227u"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(96)00018-5"},{"issue":"1","key":"e_1_3_4_38_1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1158\/0008-5472.CAN-19-1310","article-title":"Phosphorylation of RAB7 by TBK1\/IKK\u03b5 regulates innate immune signaling in triple-negative breast cancer","volume":"80","author":"Ritter JL","year":"2020","unstructured":"Ritter JL, Zhu Z, Thai TC, Mahadevan NR, Mertins P, Knelson EH, Piel BP, Han S, Jaffe JD, Carr SA, et al. Phosphorylation of RAB7 by TBK1\/IKK\u03b5 regulates innate immune signaling in triple-negative breast cancer. Cancer Res. 2020;80(1):44\u201356.","journal-title":"Cancer Res"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c01452"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-022-00940-1"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.26687"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114691"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2678"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2018.1517855"},{"issue":"13","key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.3390\/ijms21134721","article-title":"The specific IKKepsilon\/TBK1 inhibitor amlexanox suppresses human melanoma by the inhibition of autophagy, NF-kappaB and MAP kinase pathways","volume":"21","author":"M\u00f6ller M","year":"2020","unstructured":"M\u00f6ller M, Wasel J, Schmetzer J, Wei\u00df U, Meissner M, Schiffmann S, Weigert A, M\u00f6ser CV, Niederberger E. The specific IKKepsilon\/TBK1 inhibitor amlexanox suppresses human melanoma by the inhibition of autophagy, NF-kappaB and MAP kinase pathways. IJMS. 2020;21(13):4721.","journal-title":"IJMS"},{"issue":"4","key":"e_1_3_4_46_1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3906\/biy-1801-57","article-title":"IKBKE inhibits TSC1 to activate the mTOR\/S6K pathway for oncogenic transformation","volume":"42","author":"G\u00f6ktuna S.","year":"2018","unstructured":"G\u00f6ktuna S. IKBKE inhibits TSC1 to activate the mTOR\/S6K pathway for oncogenic transformation. Turk J Biol. 2018;42(4):268\u2013278.","journal-title":"Turk J Biol"},{"key":"e_1_3_4_47_1","first-page":"7046923","article-title":"A novel molecular mechanism of IKK\u03b5-mediated Akt\/mTOR inhibition in the cardiomyocyte autophagy after myocardial infarction","volume":"2020","author":"He S","year":"2020","unstructured":"He S, Shen J, Li L, Xu Y, Cao Y, Yin L, Tao Z, Qiu Z, Chen W, Chen X, et al. A novel molecular mechanism of IKK\u03b5-mediated Akt\/mTOR inhibition in the cardiomyocyte autophagy after myocardial infarction. Oxid Med Cell Longev. 2020;2020:7046923\u20137046912.","journal-title":"Oxid Med Cell Longev"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2025.2607808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T11:49:14Z","timestamp":1767700154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2025.2607808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2025.2607808"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2025.2607808","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2607808"}}